Robert Carlson MD, FACS
Areas of Expertise: Thoracic Surgery
CURRICULUM VITAE
ROBERT GREGORY CARLSON, M.D., F.A.C.S.
ADDRESS: 1901 Floyd St Suite 302
Sarasota, FL 34239
941-955-1815
MARITAL STATUS: Married
UNDERGRADUATE EDUCATION: Valparaiso University
B.S. Biology/Chemistry
Cum Laude, May 1979
Ohio State School of Dentistry
Columbus, OH
1979-1982
Wright State School of Medicine
Dayton, OH
M.D., 1986- Graduated in top 15%
INTERNSHIP: University of Florida- Shands Hospital
Gainesville, FL
General Surgery, 1986-1987
RESIDENCY: University of Florida- Shands Hospital
Gainesville, Fl
General Surgery, 1987-1982
Woodward Award- Top Surgical Resident
FELLOWSHIP: University of Florida- Shands Hospital
Gainesville, Fl
Cardiothoracic Surgery, 1992-1994
LICENSURE: Florida — ME: 0051783
Diplomat of National Board of Medical Examiners: Successful Completion Parts I, II and III
CERTIFICATION: American Board of Surgery, 2/94
American Board of Thoracic Surgery, 6/2/95
FELLOW OF AMERICAN COLLEGE OF SURGEONS(FACS)
RECERTIFICATION: American Board of Surgery, 12/03
American Board of Thoracic Surgery, 12/03
EMPLOYMENT: Robert G. Carlson, MD, FACS, PL
1901 Floyd St. Suite 302
Sarasota, FL 34239(present)
Gulf Coast Heart and Lung Surgery
1762 Hawthorne Street, Suite 4
Sarasota, FL 34239
Cardiovascular Associates
1880 Arlington Street, Suite 103
Sarasota, FL 34239
September 1996- September 1999
Heart Surgical Group
1921 Waldemere Street, Suite 814
Sarasota, FL 34239
July 1994-September 1996
AWARDS: 1. Recipient of the 1990 Resident Award for Outstanding Research from the Society for Surgery of the Alimentary tract
2. Radiological Sciences Award; 1983, 1986
3. American Heart Association Research Fellowship; 1983, 1985
4. National Resident Research Award; University of Florida, 1991
5. "America's Top Surgeons" 2002-2003 Edition. Guide to America's Top Surgeons, Consumer Research Council of America
6. 2005 Physician of the Year, NRCC award
7. "America's Top Doctors" Thoracic Surgery 2006-2007 Edition. Guide to America's Top Doctors, Castle Connolly Medical LTD.
CLINICAL APPOINTMENT:
Department Chairman- Department of Surgery, Columbia Doctors Hospital 1997-1999
MEMBERSHIPS:
American College of Surgeons
American College of Thoracic Surgeons
Florida Medical Society
Florida Society of Thoracic Surgeons
American College of Phlebology
PRIVILEGES: Sarasota Memorial Hospital- Medical Staff (retired)
Columbia Doctors Hospital- Medical Staff(retired)
MEDICAL-LEGAL: Nationally recognized expert witness with testimony/case review in:
Florida
Georgia
Texas
Virginia
Washington
Ohio
West Virginia
North Carolina
Massachusetts
South Carolina
Washington D.C.
Oklahoma
Pennsylvania
North Dakota
PUBLICATIONS:
1. Carlson RG, Morath MA, Finley RK, Jr., Miller SF, et al: Fluid retention during the first 48 hours as an indicator of burn survival. (Abstract) Proceedings of the American Burn Association 16:105, 1984.
2. Carlson RG, Miller SF, Finley RK, Jr., and Jones LM: The relationship of body surface area to fluid dynamics in severely burned patients. (Abstract) Clinical Research 33 (4): 927A, 1985.
3. Carlson RG, Miller SF, Finley RK, Jr., et al: Fluid retention and burn patient survival. (abstract ) Proceedings of the American Burn Association 18:6, 1986.
4. Carlson RG, Finley RK, Jr., Miller SK, et al: Fluid retention during the first 48 hours as an indicator of burn survival. J Trauma 26:840-843, 1986.
5. Carlson RG, Miller SF, Finley RK, Jr., Billett JM, et al: Fluid retention and burn patient survival. J Trauma 27: 127-135, 1987.
6. Carlson RG, Bagwell CE, Talbert JL: Giant breast mass in an adolescent female. Contemporary Surgery 35: 75-77, 1989.
7. Carlson RG, Fegelman E, Finley RK, Jr., Miller, SF: Assessment of the total body water in burn patients using bioelectric impedance analysis. Submitted to the Journal of Burn Care and Rehabilitation
8. Carlson RG, Mayfield WR, Normann S, and Alexander JA: Radiation associated valvular heart disease. Chest 545, 1991.
9. Hocking MP, Carlson RG, Courington KR, and Bland KI: Altered motility and bacterial flora following "functional end-to-end anastomosis". Surgery 108(2): 384-392, 1990.
10. Carlson RG, Hocking MP, Courington KR, Sninsky CA, and Vogel SB: Erythromycin enhances gastric emptying in Roux-en-Y dogs with delayed gastric emptying. AM J Surg 161:31-35, 1990?
11. Hocking MP, Carlson RG, Harrison WE, Sninsky Ca, Vogel SB; Radionuclide gastric emptying, gastric myoelectric activity and the effect of electrical pacing after gastric surgery. Surg Forum XLT: 125-127, 1990.
12. Carlson RG, Hocking MP, Sninsky CA, and Vogel SB: Erythromycin acts through a cholinergic pathway to improve canine delayed gastric emptying following vagotomy and Roux-en-Y antrectomy. J Surg Res 50: 494-498, 1991.
13. Hocking MP, Carlson RG, and Vogel SB: Selective vagotomy does not prevent delayed gastric emptying and altered myoelectric activity following Roux-en-Y gastrojejunostomy. AM J Surg
14. Carlson RG, Schiro, JC, Hertz C: Complete Myocardial Revascularization Is Safe Using Off -Pump Techniques in High Risk Elderly Patients. Am College of Cardiology (submitted for publication, but not accepted for program).
15. Sidney F. Miller,a M.D., Robert G Carlson, M.D. ,b Elliott Fegelman, M.D., c Jose Quinones, M.D. d and Robert K. Finley, Jr., M.D. a Dayton, Ohio. A comparison of Total Body Water Analyses: Bioelectric Impedance analysis Versus the Tritiate Water Method. American Burn Association, 1999.
16. Carlson RG, Schiro JC, Hertz C: Off-pump Coronary Artery Bypass in Octogenarians. MICS Symposium, May 25-27, 2000. (Abstract presentation).
PRESENTATIONS:
1. Fluid retention during the first 48 hours as an indicator of burn survival. Presented at the 16th Annual American Burn Association Meeting, San Francisco, CA, March 1984.
2. The relationship of body surface area to fluid dynamics in severely burned patients. Presented at the Midwest Medical Student Research Forum, Dayton, OH. May 1985.
3. Fluid retention and burn patient survival. Presented at the 18th Annual American Burn Association Meeting, Chicago, IL. April 1986.
4. Fluid retention and burn patient survival. Poster session at the 72nd Annual Clinical Congress of the American College of Surgeons, New Orleans, LA. October 1986.
5. Impedance and titrated water determinations of total body water in severely burned patients. Presented at the American College of Surgeons, Committee of Trauma, Florida Chapter. November 1988.
6. Erythromycin enhances gastric emptying in Roux-Y dogs with severe gastroparesis. Presented at the Society of University Resident's Program, Los Angeles, CA. February 1990.
7. Erythromycin enhances gastric emptying in Roux-Y dogs with severe delayed gastric emptying. Presented at the Society for Surgery of the Alimentary Tract, San Antonio, TX. May 1990.
8. Erythromycin acts through a cholinergic mechanism to improve delayed gastric emptying following vagotomy and Roux-Y antrectomy. Presented to the Association of Academic Surgery, November 1990.
9. Complete coronary artery revascularization using off-pump
Techniques in elderly patients. Presented at Utrecht MICABG
Workshop. Universitair Medisch Centrum, Utrecht, Netherlands.
September 4, 1999.
10. Protecting Your Heart with Proper Hormone Replacement Therapy. 4th Annual International Congress on Anti-Aging Medicine and Regenerative Biomedical Technologies. Las Vegas, Nevada December 7-10, 2006.
CLINICAL RESEARCH:
PRINCIPAL INVESTIGATOR
1. Aventis Trial HOE642/3002. "A double- blind, placebo-controlled, multi-national trial to investigate the effect of IV treatment with the Na+/H+ exchange inhibitor cariporide (HOE642) on all-cause mortality and myocardial infarction in patients at risk of myocardial necrosis during and after coronary artery bypass graft (CABG) surgery"
2. PERFECT: Perma Flow CABG Trial. Possis Medical Inc. Perma Flow Synthetic PTFE Vascular Graft SMH IRB 96-CARD-21
3. A Phase III Randomized, Parallel, Double-Blind, Multi-Center, Placebo-Controlled Study of the Effect of Pexelizumab on All-Cause Mortality and Myocardial Infarction in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery with Cardiopulmonary Bypass. Procter & Gamble Pharmaceuticals, Alexion Pharmaceuticals, Inc. Pexelizumab. PRIMO CABG Protocol #2000099.
4. A Multi-Center, Randomized, Double-Blind, Parallel-group, Placebo-Controlled Study of 2 mg/kg bolus plus 24-hour 0.05 ml/kg/hr Infusion of Pexelizumab in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery with Cardiopulmonary Bypass. (Primo 2)Proctor & Gamble Pharmaceuticals, Alexion Pharmaceuticals, Inc- Pexelizumab. Primo 2 Coronary Artery Bypass High Risk Patients -Protocol Study
CO-INVESTIGATOR
1. AVANT Immunotherapeutics, Inc. TP-10ACS-001. A Study of the Safety and Efficacy of TP-10 (SCR1) In the Prevention of Post Cardiopulmonary Bypass Syndromes in Adults.
2. OXYGENT TM CPB I 1999 Alliance Pharmaceuticals Corp., Protocol #OXHT-017-INT.
3. PROTOCOL# CGT003-04 A Phase III, Multi-Center,Randomized,Double-Blind Placebo Controlled Trial Of EX-VIVO Treatment With CGT003 Of Coronary Vein Grafts In Patients Undergoing Coronary Artery Bypass Grafting Procedures.
4. A Phase 2 Randomized Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Recombinant Soluble Complement Receptor Type 1 (TP 10) in Adult women Undergoing Cardiopulmonary Bypass Surgery.
5. A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study
To Evaluate The Cardioprotective Effects of MC-1 In Patients Undergoing High-Risk Coronary Artery Bypass Graft (CABG) Surgery. Mend-CABG II, Medicure International Inc, Clinical Research Protocol # 06004